SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-003365
Filing Date
2017-06-26
Accepted
2017-06-26 16:36:04
Documents
43
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT s106657_10q.htm 10-Q 226329
2 EXHIBIT 31.1 s106657_ex31-1.htm EX-31.1 12884
3 EXHIBIT 31.2 s106657_ex31-2.htm EX-31.2 12959
4 EXHIBIT 32.1 s106657_ex32-1.htm EX-32.1 7044
5 EXHIBIT 32.2 s106657_ex32-2.htm EX-32.2 6550
  Complete submission text file 0001615774-17-003365.txt   1315636

Data Files

Seq Description Document Type Size
6 XBRL PRESENTATION FILE shph-20170331_pre.xml EX-101.PRE 100480
7 XBRL INSTANCE FILE shph-20170331.xml EX-101.INS 142241
8 XBRL SCHEMA FILE shph-20170331.xsd EX-101.SCH 16964
9 XBRL CALCULATION FILE shph-20170331_cal.xml EX-101.CAL 29590
10 XBRL DEFINITION FILE shph-20170331_def.xml EX-101.DEF 42201
11 XBRL LABEL FILE shph-20170331_lab.xml EX-101.LAB 129050
Mailing Address 1 RESEARCH COURT SUITE 450 ROCKVILLE MD 20850
Business Address 1 RESEARCH COURT SUITE 450 ROCKVILLE MD 20850 (240) 403-4212
Shuttle Pharmaceuticals, Inc. (Filer) CIK: 0001685462 (see all company filings)

IRS No.: 461747648 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-215027 | Film No.: 17930200
SIC: 2834 Pharmaceutical Preparations